Abstract:Background and Objectives: Over the last years, inflammatory bowel disease (IBD) has been reported on a high incidence in pediatric populations and has been associated with numerous extraintestinal manifestations, making its management a real challenge for the pediatric gastroenterologist. Dermatological manifestations in IBD are either specific, related to the disease activity or treatment-associated, or non-specific. This literature review aims to identify and report the dermatological manifestations of IBD in children, the correlation between their appearance and the demographical characteristics, the relationship between these lesions and disease activity, and to highlight the impact of dermatological manifestations on an IBD treatment regime. Materials and methods: A systemic literature review was performed, investigating articles and case reports on dermatological manifestations in children with IBD starting from 2005. A total of 159 potentially suitable articles were identified and after the exclusion process, 75 articles were selected. Results: The most common dermatological manifestations reported in pediatric IBD are erythema nodosum and pyoderma gangrenosum. More rare cases of metastatic Crohn's disease, epidermolysis bullosa acquisita, small-vessel vasculitis, necrotizing vasculitis, leukocytoclastic vasculitis, cutaneous polyarteritis nodosa, and Sweet's syndrome have been reported. Oral manifestations of IBD are divided into specific (tag-like lesions, mucogingivitis, lip swelling with vertical fissures, aphthous stomatitis, and pyostomatitis vegetans) and non-specific. IBD treatment may present with side effects involving the skin and mucosa. Anti-tumor necrosis factor agents have been linked to opportunistic skin infections, psoriasiform lesions, and a potentially increased risk for skin cancer. Cutaneous manifestations such as acrodermatitis enteropathica, purpuric lesions, and angular cheilitis may appear secondary to malnutrition and/or malabsorption. Conclusions: The correct diagnosis of dermatological manifestations in pediatric IBD is of paramount importance because of their impact on disease activity, treatment options, and a patient's psychological status.

Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview

Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations

Skin Manifestations of Inflammatory Bowel Disease

Dermatologic manifestations of inflammatory bowel disease: a review.

Nonmalignant dermatologic disorders in Inflammatory Bowel Disease

Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management

Rheumatologic and extraintestinal manifestations of inflammatory bowel diseases

Cutaneous manifestations associated with inflammatory bowel disease

Extraintestinal Manifestations in Inflammatory Bowel Disease: From Pathophysiology to Treatment

[Cutaneous involvement in chronic inflammatory bowel disease : Crohn's disease and ulcerative colitis]

Manifestations Reported by Inflammatory Bowel Disease Patients in University Hospital

Dermatological Manifestations in Pediatric Inflammatory Bowel Disease

Clinical management of the most common extra-intestinal manifestations in patients with inflammatory bowel disease focused on the joints, skin and eyes

Ocular, Auricular, and Oral Manifestations of Inflammatory Bowel Disease

The extraintestinal manifestation of inflammatory bowel disease:clinic study of 201 cases

Gastrointestinal Conditions: Inflammatory Bowel Disease.

Ophthalmological Manifestations in Inflammatory Bowel Diseases: Keep an Eye on It

Clinical Manifestations and Therapy of Extraintestinal Manifestations with Inflammatory Bowel Disease

Current Insights on the Roles of Gut Microbiota in Inflammatory Bowel Disease-Associated Extra-Intestinal Manifestations: Pathophysiology and Therapeutic Targets

Dermatologic manifestations in pediatric patients with inflammatory bowel disease

Ocular Manifestations of IBD: Pathophysiology, Epidemiology, and Iatrogenic Associations of Emerging Treatment Strategies